STADE‐HF (sST2 As a help for management of HF): a pilot study

AIMS: Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre‐discharged sST2 values as a guide for medical management in patients admitted...

Descripción completa

Detalles Bibliográficos
Autores principales: Huet, Fabien, Nicoleau, Jean, Dupuy, Anne‐Marie, Curinier, Corentin, Breuker, Cyril, Castet‐Nicolas, Audrey, Lotierzo, Manuela, Kalmanovich, Eran, Zerkowski, Laetitia, Akodad, Mariama, Adda, Jérôme, Agullo, Audrey, Leclercq, Florence, Pasquie, Jean‐Luc, Battistella, Pascal, Roubille, Camille, Fesler, Pierre, Mercier, Grégoire, Bourel, Guillaume, Cristol, Jean‐Paul, Roubille, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160465/
https://www.ncbi.nlm.nih.gov/pubmed/32168423
http://dx.doi.org/10.1002/ehf2.12663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160465/
https://www.ncbi.nlm.nih.gov/pubmed/32168423
http://dx.doi.org/10.1002/ehf2.12663

Ejemplares similares